Franz Jansen
20Patents
6h-index
13Co-inventors
66Inventor score
Filing activity: Sep 27, 1979 → Oct 4, 2000
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4414148A | Anti-cancer drugs for the treatment of melanomas and method for preparing thereof | Emerging Cross-Sectional Technologies | 170 | Expired |
| US4340535A | Cytotoxic products formed by covalent bonding of the A chain of ricin with an antibody and the process for their preparation and use | Emerging Cross-Sectional Technologies | 80 | Expired |
| US4980457A | Cytotoxic conjugates which can be used in therapy and process for their preparation | Human Necessities | 34 | Expired |
| US4762707A | New conjugates associating, by covalent bond, an enzyme with an antibody, and medicinal associations using the said conjugates | Chemistry; Metallurgy | 22 | Expired |
| US6319615A | Use of a thermal spray method for the manufacture of a heat insulating coat | Emerging Cross-Sectional Technologies | 13 | Expired |
| US4670563A | Imidazolides as intermediates for the synthesis of cytotoxic conjugates | Human Necessities | 6 | Expired |
| US4906469A | Appropriate cytotoxic pharmaceutical combination especially for the treatment of cancers | Emerging Cross-Sectional Technologies | 5 | Expired |
| US4643895A | Anti-cancer drugs for the treatment of leukaemias I, constituted by the chain A of ricin and a specific monoclanal antibody | Emerging Cross-Sectional Technologies | 5 | Expired |
| US6221175A | Method for the production of a ceramic layer on a metallic base material | Emerging Cross-Sectional Technologies | 4 | Expired |
| US4767621A | Drugs comprising in association at least one immunotoxin and at least one monovalent carboxylic ionophore | Emerging Cross-Sectional Technologies | 4 | Expired |
| US4582703A | Cytotoxic medicament formed from the association of at least one immunotoxin and chloroquin | Human Necessities | 4 | Expired |
| US4614650A | Cytotoxic composition including at least an immunotoxine and an amine | Human Necessities | 3 | Expired |
| US6194084A | Thermal spray powder of dicalcium silicate and coating thereof and manufacture thereof | Emerging Cross-Sectional Technologies | 3 | Expired |
| US4919928A | Conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, their use as immunotoxin potentiators and the intermediate activated ionophores | Chemistry; Metallurgy | 3 | Expired |
| US6524704B1 | Thermal spray powder of dicalcium silicate and coating thereof and manufacture thereof | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5185434A | Prolonged-action immunotoxins containing a glycopeptide constituent which inactivates ribosomes, modified on its polysaccharide units | Human Necessities | 1 | Expired |
| US6184399A | Process for preparing a fatty acyl isethionate salt | Chemistry; Metallurgy | 1 | Expired |
| US5144009A | Conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, their use as immunotoxin potentiators and the intermediate activated inophores | Chemistry; Metallurgy | 0 | Expired |
| US4919927A | Process for the potentiation of immunotoxins | Emerging Cross-Sectional Technologies | 0 | Expired |
| US4977280A | Conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, their use as immunotoxin potentiators and the intermediate activated ionophores | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.